Suchergebnisse - "Fu, Haoda"

PubPharm (11)

1

Risk controlled decision trees and random forests for precision Medicine

enthalten in: Statistics in medicine | 2022

von Doubleday, K. | Zhou, J. | Zhou, H. | +1

2

Net benefit index : Assessing the influence of a biomarker for individualized treatment rules

enthalten in: Biometrics | 2021

von Zhou, Y. | Song, P. | Fu, H.

3

On using electronic health records to improve optimal treatment rules in randomized trials

enthalten in: Biometrics | 2020

von Wu, P. | Zeng, D. | Fu, H. | +1

4

Trifluridine/tipiracil in metastatic gastric cancer

enthalten in: The Lancet. Oncology | 2019

von McCaw, Z. | Kim, D. | Tian, L. | +2

CommentOn: Lancet Oncol. 2018 Nov;19(11):1437-1448. - PMID 30355453

5

Quantifying the totality of treatment effect with multiple event-time observations in the presence of a terminal event from a comparative clinical study

enthalten in: Statistics in medicine | 2018

von Claggett, B. | Tian, L. | Fu, H. | +2

6

Estimating individualized treatment rules for ordinal treatments

enthalten in: Biometrics | 2018

von Chen, J. | Fu, H. | He, X. | +2

7

Efficiency of two sample tests via the restricted mean survival time for analyzing event time observations

enthalten in: Biometrics | 2018

von Tian, L. | Fu, H. | Ruberg, S. | +2

8

Interpretability of Cancer Clinical Trial Results Using Restricted Mean Survival Time as an Alternative to the Hazard Ratio

enthalten in: JAMA oncology | 2017

von Pak, K. | Uno, H. | Kim, D. | +6

9

Detecting outlying trials in network meta-analysis

enthalten in: Statistics in medicine | 2015

von Zhang, J. | Fu, H. | Carlin, B.

10

Alternatives to Hazard Ratios for Comparing the Efficacy or Safety of Therapies in Noninferiority Studies

enthalten in: Annals of internal medicine | 2015

von Uno, H. | Wittes, J. | Fu, H. | +7